Partnering opportunity

Molecular oncology diagnostic tool in targeted therapy


Italian biotech spin-off company working in the oncology field, integrated with clinical activities of a research institute, offers a broad range of diagnostic tool, from molecular diagnostic to pathology and cytofluorimetry. The methodology is aimed to the diagnostic needs of clinicians and laboratories. Biotech, pharmaceutical and research companies are sought for joint venture and/or research cooperation agreements.

Partner sought

The Italian company is seeking biotech, pharmaceutical and diagnostic companies interested for joint venture agreements, involving in clinical trials expertise, diagnostics development, interested to acquire the new therapeutic tool proposed. E.g. gynecologist for the detection and typing HPV (Human Papilloma Virus) for detection agents relevant in female health control screening and diagnosis. The company is also looking for R&D institutions for participating in European calls for proposal.


The Italian company offers a full range of histology and cytology tests for oncology. Stemming from the clinical experience the molecular tests are based on the choice of the most important genes involved in the targeted therapy and differential diagnostics. They are available either as single-test format, or in panel based on Next Generation Sequencing (NGS), targeted for differential clinical needs. The test can be combined in a customized format providing a flexible and broad menu covering all the currently actionable molecular signatures. A constant update of new drugs/diagnostics development is a major focus of the approach proposed. It allows to immediately exploit the most advanced therapeutic and diagnostic opportunities. The diagnostic branch of research centre, strictly integrated with the clinical activities, offers a broad range of diagnostic tests in the fields of oncology such as gynecological tumors. Its engagement in the front-edge research projects paves the way for catching new opportunities in diagnostic, and making them available to the clinics. The Precision Medicine world is a reality in everyday patient management. This new paradigm implies new challenge and efforts to make this emerging diagnostics services really user-friendly, cost-effective and quick in delivery of results. Most important for exploiting the full potential of personalized medicine is the correct classification and characterization of samples, and, in oncohematology, the featuring of phenotypic markers for differential diagnosis and patient monitoring. The molecular analysis are systematically integrate with careful evaluation and validation of the samples, for the subsequent correct analysis of the molecular signatures of the tumor. The Italian company is seeking biotech, pharmaceutical and diagnostic companies interested in clinical trials expertise, diagnostics development, new therapeutic tools for joint venture agreements. An example of application is gynecological tumors which represent heavy burden to female patients, the detection and typing HPV (Human Papilloma Virus) for the identification of agents, control screening and diagnosis. The company is also looking for research cooperation for participating in European calls for proposal.

Advantages and innovations

The advantages are based on the selection of the most important genes in the targeted therapy an differentia diagnostic, consequently --personalized medicine; --therapy Monitoring; --customized format. The diagnostic tool is based on unique innovative expertise aimed to offer a complete, scientifically and technically assistance to the partners involved in this rapidly evolving fields.

Development stage

Already on the market

Intellectual Property Rights (IPR)

Secret Know-how,Exclusive Rights,Other

Register your interest

How it works

  • Tell us about yourself
  • We’ll discuss with you
  • We put the right partners in touch

EEN help you find the right partner, rather than you going it alone.

Our role is to review and collate the most suitable submissions, and then send them to the client who posted the opportunity. We consult with you, and the client, to make the process professional and easy.

These are live opportunities. Your registration of interest on the site is just like a professional approach to a business at a networking event. To stand the best chance of success, make your submission really sing. Sell why the client who posted the opportunity should work with you. Excite them. Ask questions. Try and avoid copy and pasting words from elsewhere.

Once the client has chosen their partner, we'll introduce them over email and keep in touch with both parties to see how it's going. Sometimes things progress quickly. Sometimes because of changing priorities for either party, things progress slowly, but you never know - your next big business break could start right here.

?What value does EEN add?
This is your pitch: remember to include your unique selling points (USP) and why someone would want to do business with you
Tell us why you are a good fit for this opportunity, and why you think you're the right people for this partnership
If there's anything additional, or commercially sensitive you'd like to know about this opportunity, please let us know

When you entered your email address above, we emailed you a code to verify you're human and have access to that account.

?What's this?

What next?

To finish up, we just need some extra details about you and your company